Please try another search
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Fahar Merchant | 66 | 2011 | Founder, Chairman, President & CEO |
John H. Sampson | 56 | 2021 | Independent Director |
Albert George Beraldo | 70 | 2016 | Lead Independent Director |
Karen A. Dawes | 71 | 2019 | Independent Director |
Sergio A. Quezada | 47 | 2022 | Chairman of Scientific Advisory Board |
John Geltosky | 77 | 2020 | Independent Director |
William L. Redmond | - | 2022 | Member of Scientific Advisory Board |
Kapil Dhingra | 64 | 2022 | Strategic Advisor |
David J. Mooney | - | 2022 | Member of Scientific Advisory Board |
Paolo Antonio Ascierto | - | 2022 | Member of Clinical Advisory Board |
Lillian L. Siu | - | 2022 | Member of Clinical Advisory Board |
Burkhard Becher | - | 2022 | Member of Scientific Advisory Board |
Hussein A. Tawbi | - | 2022 | Member of Clinical Advisory Board |
Karim F. Lalji | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review